USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12277
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTontici, Ecaterina-
dc.date.accessioned2020-10-21T08:58:09Z-
dc.date.available2020-10-21T08:58:09Z-
dc.date.issued2020-
dc.identifier.citationTONTICI, Ecaterina. Treatment in a cohort of patients with gout. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 160-161.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12277-
dc.descriptionDepartment of Internal Medicine Rheumatology and Nephrology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020en_US
dc.description.abstractIntroduction. The actuality of the studied subject is conditioned by the increase of the prevalence of gout. Gout arises following the deposition of uric acid crystals in joints as a consequence of hyperuricemia. Frequent co-morbidities, non-compliance of the patients to treatment and the contribution to other organ involvement: cardiovascular diseases, severe nephropathy, disability, all these are major problems that make gout control difficult. The drugs of choice for acute gouty arthritis are nonsteroidal anti-inflammatory drugs (NSAID), colchicine and corticosteroids. Treatment with xanthine oxidase inhibitors or uricosuric drugs is indicated for the long term and the end target is the value of uric acid <360 mcmol/l, and even 300 mcmol/L in patients with advanced tophaceous gout. Aim of the study. Analysis of uric acid lowering therapy, prophylactic treatment of gout flairups and treatment strategy in acute gout attack. Materials and methods. A retrospective study was done on patients diagnosed with gout and hospitalized in the arthrology department of the Republican Clinical Hospital for the year 2018. In the number of 66 patients, 56 of the being males and 10 females, having average age - 58 years. Results. It was found that the average age of the disease debut was 44 years for males and 52 for females. Before hospitalization as the basic treatment 77% of the patients used allopurinol and 23% - febuxostat. 45% of them didn’t administer the treatment on a regular basis, among this group the average level of uric acid was 553 mcmol/l. On the other side, for the group which used to follow to treatment (55%) this indicator was 401 mcmol/l. In the hospital for the acute gout attack in 65% of cases NSAID were used, in 3% - colchicin and the other 29% - combined therapy (NSAID and colchicin). In 53% of cases intraarticular corticosteroids were used. As a basic treatment it was found that for the 83,4% was indicated allopurinol and for the 16,6% febuxostat. Conclusions. I have found correlation between the level of uric acid and compliance with the treatment. Also studied treatment methods of gout depends on the stage of the disease, age of patient, and concomitant diseases.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectgouten_US
dc.subjecttreatmenten_US
dc.subjecturic aciden_US
dc.titleTreatment in a cohort of patients with gouten_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2020

Files in This Item:
File Description SizeFormat 
Tontici_Ecaterina.pdf340.38 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback